Taro Pharmaceutical Industries Ltd. announced that Mr. Uday Baldota has joined the company as its Chief Executive Officer effective August 28, 2017. Since December 2016, Mr. Baldota has served as a member of company’s Board of Directors. Mr. Baldota replaces Mr. Abhay Gandhi, who served in the role of Interim Chief Executive Officer since January 1, 2017. Mr. Gandhi will continue in his role as Vice Chairman of the company's Board and as the CEO of the Sun Pharma North America operations.